Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Using tamsulosin with finasteride is the most effective and reduces surgery risk for BPH.

A woman's small ovarian tumor causing high androgen levels was missed by several scans but found during surgery.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Popliteal Artery Entrapment Syndrome (PAES) is a rare but possible cause of leg pain during walking, even in untrained women.

Finasteride exposure in pregnancy causes genital abnormalities in male rats.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Mesothelioma of the tunica vaginalis testis is rare, often high-grade, and has a median survival of about 24 months.

Finasteride therapy reduces PSA levels and prostate size, helping diagnose prostate cancer.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Tailored treatment is crucial for elderly men with BPH due to potential risks and benefits of medications.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Finasteride may help reduce tic severity in male Tourette syndrome patients.

The new saw palmetto extract effectively inhibits an enzyme linked to prostate enlargement and may be as good as standard treatments.

A man grew hair on his penis, which is not common, and needed surgery to remove it.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Tadalafil is effective for treating urinary symptoms in men with BPH.

EGFR inhibitors can cause unusual localized hair growth.

New treatments for long-lasting erections improve outcomes but must be timely to avoid lasting damage.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.